Charitable organizations are seeing more and more patients who need financial assistance, said Dan Klein, President and CEO, Patient Access Network (PAN) Foundation.
Charitable organizations are seeing more and more patients who need financial assistance, said Dan Klein, President and CEO, Patient Access Network (PAN) Foundation.
Transcript
More people are getting insurance, but plans are also shifting more financial burden to patients. Have changes like these resulted in any changes that you’ve seen from your end of providing financial assistance to patients?
We’re seeing more and more patients with high-deductible plans and more patients in Medicare who are reaching the catastrophic threshold. And, as a result, we’re seeing more demand for the types of grants and assistance that we provide. The numbers just seem to grow every year, and it’s a challenge to keep up.
We mainly serve Medicare patients—so about 85% to 90% of the patients we serve are on Medicare. As a result of the Affordable Care Act rolling out, obviously more people did get coverage, but those aren’t really the people who generally come to us for grants. Now, what’s potentially change is, one, people are coming off the Affordable Care Act coverage because of the changes that the new administration has put in place and, also, there’s this new emerging trend of something called accumulator adjusters that may make manufacturer coupons less useful for patients with commercial coverage. So those patients might start to look to charitable foundations like PAN for assistance. So, we could see an increase as a result of that.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
POSITIVE Trial Update on Patients With Breast Cancer Attempting Pregnancy
December 8th 2023At last year’s San Antonio Breast Cancer Symposium, POSITIVE trial primary outcome data were presented on breast cancer–free interval, with women who paused endocrine therapy to attempt pregnancy having a similarly small rate of recurrence vs external controls from the SOFT and TEXT trials: 8.9% vs 9.2%.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
New Insights on Breast Cancer Outcomes Among Sexual, Gender Minorities
December 7th 2023Despite there being a great demand for data collection on sexual orientation and gender identity in the cancer space, individuals who identify as a sexual and gender minority remain poorly represented.
Read More
Refining Precision Prevention for Benign Breast Disease
December 7th 2023Many questions remain surrounding accurately classifying the risk of developing invasive breast cancer associated with the benign breast disease diagnoses of nonproliferative lesions and proliferative changes without atypia.
Read More